Risks: Rejection, Procedure Safety, and Business Challenges

Michael Hufford is the co-founder and CEO of LyGenesis, a company working on a new treatment for end stage liver disease. Michael’s problem is this: How do grow a new liver inside the body of a sick patient?

In this episode, Michael explains: 

• The liver's unique power of regeneration
• The organ transplant crisis and how regeneration can help 
• The science behind using lymph nodes to grow new organs
• The status of LyGenesis’ human trials
• The future of regenerative medicine 

Learn more:

• Check out LyGenesis’ website

Connect with us:

• Follow Jacob Goldstein on LinkedIn, X and Instagram 
• Email us at problem@pushkin.fm 
• Follow Pushkin on Instagram, LinkedIn or X 
• Listen to Jacob’s other show, Business History 
• To listen to the show early and ad free, sign up for Pushkin+

See omnystudio.com/listener for privacy information.